Cyclerion Therapeutics, Inc.
CYCNNASDAQHealthcareBiotechnology
As of Oct 14, 2026 close
- Market cap
- $14.28M
- P/E (TTM)
- -
- Forward P/E
- -
- Dividend yield
- -
- 52-week range
- $1.03$36.33
- Volume (live)
- -
- Avg. volume (3M)
- 54.35K
Cyclerion Therapeutics (CYCN) Stock Price & Financial Analysis
Cyclerion Therapeutics Stock Price Chart
Loading chart...
Financial Metrics & Key Statistics
Fundamental metrics, valuation ratios, and profitability indicators
| Day's Range | $23.52 - $23.52 |
|---|---|
| 52-Week High | $36.33 |
| 52-Week Low | $1.03 |
| Open | $3.72 |
| Volume (last close) | 435.85K |
| Average Volume (3M) | 54.35K |
| Revenue (TTM) | 1.99M |
|---|---|
| Net Income (TTM) | -6.71M |
| Free Cash Flow (TTM) | -4.52M |
| EPS (TTM) | −$1.80 |
| Profit Margin | -336.53% |
| Operating Margin | -342.40% |
| Return on Equity (ROE) | -131.85% |
| Debt to Equity | 0.00 |
| Annual Dividend | $0.00 |
|---|---|
| Dividend Yield | 0.00% |
| Market Cap | 14.28M |
|---|---|
| Shares Outstanding | 4.25M |
| Price to Sales (P/S) | 7.17 |
| Price to Book (P/B) | 2.81 |
| EV/EBITDA | -1.91 |
| 50-Day MA | $25.83 |
|---|---|
| 200-Day MA | $9.44 |
| 1-Year Change | +57.75% |
Source: Market prices and company fundamentals. Data as of Oct 14, 2026. Data sources and methodology
Cyclerion Therapeutics at a Glance
As of the Oct 14, 2026 close, Cyclerion Therapeutics (CYCN) has a market capitalization of $14.28M. The stock trades at 7.2× sales. Over the trailing twelve months it lost $6.71M on revenue of $1.99M and burned $4.52M of free cash flow. Revenue fell 4.2% year over year.
As of its latest reported balance sheet, it holds $1.39M in cash and securities against $0.00 of debt, a net cash position of $1.39M.
Cyclerion Therapeutics does not currently pay a dividend.
The share price is up 57.7% over the past year. At $3.36 (the Oct 14, 2026 close) it sits near the bottom of its 52-week range of $1.03 to $36.33, below its 200-day moving average of $9.44.
Frequently Asked Questions About Cyclerion Therapeutics
What is the current stock price for CYCN?
As of the Oct 14, 2026 close, CYCN stock trades at $3.36. The 52-week range is $1.03–$36.33, with a day range of $23.52–$23.52.
What is the P/E ratio for CYCN?
The P/E ratio (Price-to-Earnings) for CYCN is shown in the Key Statistics section. This valuation metric helps compare Cyclerion Therapeutics, Inc. to industry peers.
Does CYCN pay dividends?
Cyclerion Therapeutics does not currently pay a regular dividend. It reported a net loss over the trailing twelve months, so it has no earnings to distribute. Check the Dividends tab for historical dividend information.
What do analysts recommend for CYCN?
Analyst ratings and recommendations for CYCN are displayed in the Analyst Consensus section, including buy/hold/sell distribution and 12-month price targets.
What is the market cap of CYCN?
As of the Oct 14, 2026 close, Cyclerion Therapeutics's market capitalization is $14.3M, classifying it as a micro-cap company. Cyclerion Therapeutics operates in the Healthcare sector within the Biotechnology industry.